This seminar will consider global coordination to tackle antimicrobial resistance (AMR) and the next steps for meeting the goals of the UK strategy.
The agenda includes keynote addresses from Professor Hanan Balkhy, Assistant Director-General, Antimicrobial Resistance, World Health Organisation and Professor Dame Sally Davies, formerly Chief Medical Officer for England and newly-appointed UK Special Envoy on AMR for UK Government.
It is timed to bring together stakeholders and policymakers to discuss the way forward for global collaboration to tackle AMR, in light of the recent report from the UN Interagency Coordination Group on Antimicrobial Resistance’s No Time to Wait: Securing the future from drug-resistant infections which called for systematic and meaningful engagement across sectors at the global, national and local level.
Priorities for antibiotic development
The seminar takes place following the announcement of the trial of a new payment model for antibiotics by NICE and NHS England and NHS Improvement, which would pay pharmaceutical companies upfront for the value of their medicines rather than by volume of antibiotic used.
Delegates will consider what will be needed from a new payment model to encourage the development of new antimicrobials, whilst ensuring that companies get the return on the investment required to develop new drugs, without incentivising the overuse of antibiotics.
Delivering the UK AMR strategy
We expect further discussion on the next steps for meeting the goals of the UK Government’s 5-year action plan and 20-year vision for AMR.
Attendees will assess the impact of the plan and the way forward for delivering key ambitions - including improving infection prevention and control, strengthening surveillance capacity and collaborating across the human, animal and environmental health sectors.
Ensuring appropriate antibiotic use
Further sessions will consider the Government’s review into overprescribing and how to encourage the appropriate use of antibiotics, looking at increasing patient awareness of AMR, improving diagnostic testing of infections and engaging with clinicians, vets and farmers to reduce antibiotic use.
The agenda in summary
- Strengthening global coordination to tackle AMR;
- Priorities for research - collaboration, encouraging innovation and financial incentives for developing new antimicrobials;
- Improving the prevention and control of infections;
- Ensuring appropriate prescribing - improving diagnostics, engaging with clinicians and managing patient expectations;
- Next steps for meeting the goals of the UK AMR strategy.